{"schema_version":"secwatch.filing_event.v1","accession":"0000805928-23-000151","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2023-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.049672+00:00","generated_at":"2026-06-07T17:37:15.468034+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Axogen appoints Nir Naor as CFO; Peter Mariani departs; FY2023 revenue guidance reaffirmed $154-159M","bullets":["Nir Naor appointed CFO effective Dec 4, 2023, replacing Peter Mariani who stepped down at Board's request.","Naor receives base salary $475K, target bonus 60%, and inducement grant of 300,000 RSUs vesting over 3 years.","Mariani remains for brief transition; separation terms under discussion.","Company reaffirms FY2023 revenue guidance of $154-159M (11-15% growth) and gross margin ~80%."],"urls":{"canonical":"https://secwatch.observer/filing/0000805928-23-000151","json":"https://secwatch.observer/filing/0000805928-23-000151.json","markdown":"https://secwatch.observer/filing/0000805928-23-000151.md","text":"https://secwatch.observer/filing/0000805928-23-000151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000151/0000805928-23-000151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000151/axgn-20231204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T17:37:15.468034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68c400d514","claim":"Peter Mariani departed as Executive Vice President and Chief Financial Officer at Axogen, Inc..","evidence_excerpt":"Effective upon Mr. Naor’s appointment, Peter Mariani stepped down from his role as the Executive Vice President and Chief Financial Officer of the Company and Axogen Corporation, a Delaware corporation (“AC”) and wholly owned subsidiary of the Company, at the request of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000151/0000805928-23-000151-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"857e477e9f","claim":"Nir Naor was appointed as Chief Financial Officer at Axogen, Inc..","evidence_excerpt":"On December 6, 2023, Axogen, Inc. (the “Company”) announced the appointment of Nir Naor as Chief Financial Officer, effective December 4, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000151/0000805928-23-000151-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}